Miguel Teran/LinkedIn
Sep 10, 2026, 16:07
Miguel Teran: Why ROTEM Will Redefine Major Bleeding Management
Miguel Teran, Anesthesiologist at Hospital Luis F. Nachón, shared a post on LinkedIn:
”A prediction: in a few years, managing major bleeding without understanding ROTEM will be comparable to practicing medicine without knowing how to read an ECG.
We are moving from fixed transfusion ratios such as 1:1:1 toward individualized, goal-directed hemostatic resuscitation.
ROTEM helps us answer the question that really matters:
What is this patient actually missing?
Fibrinogen?
Coagulation factors?
Platelet contribution?
Is there fibrinolysis?
The goal is no longer simply to transfuse blood products.
The goal is precision hemostasis.”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 16:53Flora Peyvandi: A New Approach to Coagulation with Bispecific Antibodies
-
Sep 10, 2026, 16:52Francisco Chacón-Lozsán: Perhaps We Are Treating ‘Sepsis’ When We Should Be Treating an Immune Phenotype
-
Sep 10, 2026, 16:46Aswin K Mohan: HLA Beyond Histocompatibility – Redefining Immune Recognition in Modern Medicine
-
Sep 10, 2026, 16:40Satyam Arora: Pediatric Apheresis – When Every Millilitre Matters
-
Sep 10, 2026, 16:39Marco Moscarelli: When CT Reveals Thrombosis After TAVI
-
Sep 10, 2026, 16:23Antonio Paul: When a Low Platelet Count Does Not Mean Weak Clotting
-
Sep 10, 2026, 16:12Balancing Thrombosis and Bleeding in Antiphospholipid Syndrome
-
Sep 10, 2026, 16:04Isaac Okello: Where Skyline Meets Savannah – Quiet Moments at GASCDO in Nairobi
-
Sep 10, 2026, 15:58Joyisa Deb: How Immune Recognition Reshapes Clinical Practice